Skip to main content
SpringerLink
Log in

Methotrexate: no increased risk of lung disorders

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Conway R, et al. Methotrexate use and risk of lung disease in psoriasis, psoriatic arthritis, and inflammatory bowel disease: systematic literature review and meta-analysis of randomised controlled trials. BMJ 2015: h1269, No. 350, 13 Mar 2015. Available from: URL: http://dx.doi.org/10.1136/bmj.h1269

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Methotrexate: no increased risk of lung disorders. Reactions Weekly 1545, 10 (2015). https://doi.org/10.1007/s40278-015-9101-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-015-9101-7

Search

Navigation